Streetbeat News

Revenues

PDD

PDD Holdings (NASDAQ:PDD) has significantly outperformed the market over the past 5 years, with an average annual return of 32.26%. A $1000 investment in PDD 5 years ago would now be worth $4,096.51, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 7:30 pm

AAP

F

GM

STLA

Advance Auto Parts (AAP) shares dropped 5.3% due to weak guidance from Stellantis, impacting the auto sector. Stellantis revised its fiscal 2024 guidance, affecting automakers like GM and Ford. This signals potential challenges for the automotive and aftermarket parts industries.

Portfolio Pulse from Henry Khederian

September 30, 2024 | 7:17 pm

F

GM

Shares of General Motors (GM) and Ford (F) are trading lower due to sector-wide weakness after Stellantis (STLA) lowered its 2024 guidance, citing challenges in North America and global industry deterioration.

Portfolio Pulse from Vaishali Prayag

September 30, 2024 | 7:13 pm

CORT

TEVA

Truist Securities has raised the price target for Corcept Therapeutics (NASDAQ:CORT) due to impressive sales of its drug Korlym, despite increased competition. The company is also advancing its relacorilant trials, which could significantly boost future revenues. Meanwhile, Teva Pharmaceuticals (NYSE:TEVA) has filed a lawsuit against Corcept, alleging anti-competitive practices.

Portfolio Pulse from Vandana Singh

September 30, 2024 | 7:02 pm

INSP

In the past three months, 7 analysts have rated Inspire Medical Systems (NYSE:INSP), with a mix of bullish and somewhat bullish sentiments. The average 12-month price target is $222.86, a 6.7% decrease from the previous target. Analysts have adjusted their ratings and price targets based on market conditions and company performance. Inspire Medical Systems has shown a positive revenue growth rate of 29.65% but faces challenges with net margin and return on equity.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 7:01 pm

WBS

Webster Financial Corp (NYSE:WBS) has received mixed analyst ratings over the past three months, with a recent decline in average price targets. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Despite challenges in revenue growth and returns, the company maintains strong profitability and effective debt management.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 7:01 pm

VNOM

Viper Energy (NASDAQ:VNOM) has been evaluated by 8 analysts over the past three months, with a mix of bullish and somewhat bullish ratings. The average 12-month price target has increased by 7.45% to $50.5. Analysts have adjusted their ratings and price targets, reflecting positive sentiment and expectations for Viper Energy's future performance. The company has shown strong financial performance with significant revenue growth and profitability, although it has a higher debt-to-equity ratio than the industry average.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 7:00 pm

ZION

Zions Bancorp (NASDAQ:ZION) has been analyzed by 16 analysts, showing a range of perspectives from indifferent to somewhat bearish. The average 12-month price target is $51.38, up from $46.67. Analysts have adjusted their ratings and price targets, reflecting changing market dynamics and company performance. Zions Bancorp faces revenue challenges but has a strong return on equity and balanced debt management.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 7:00 pm

CPRT

Copart (NASDAQ:CPRT) has significantly outperformed the market over the past 5 years, with an average annual return of 21.14%. A $100 investment in CPRT 5 years ago would now be worth $263.37. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 7:00 pm